Literature DB >> 27134472

Lycopene in cancer therapy.

Vagish Kumar Laxman Shanbhag1.   

Abstract

Entities:  

Year:  2016        PMID: 27134472      PMCID: PMC4832910          DOI: 10.4103/0975-7406.171740

Source DB:  PubMed          Journal:  J Pharm Bioallied Sci        ISSN: 0975-7406


× No keyword cloud information.
Sir, The article “Naturally occurring products in cancer therapy” in the dental science section of the journal was read with interest.[1] Though lycopene was mentioned in the article, its role and mechanism of action against cancer was missing. This article aims to fill this void. Lycopene is a red carotenoid found in ripe tomatoes, grapefruits, and red watermelon with anti-oxidant, anti-inflammatory, and chemopreventive properties against cancer.[2345] Its absorption into the human body is more efficient when consumed from heated and lipid-rich dietary sources than raw sources.[4] It is observed to accumulate in the prostate and has anti-proliferative and pro-apoptotic activities against prostate cancer.[6] Lycopene quenches singlet oxygen, scavenges free radicals, and prevents the oxidative damage of DNA. Thus, it prevents potential transformation of normal cells to cancer cells.[45] It also modulates gene functions, carcinogen-metabolizing enzymes, apoptosis, and immune function.[45] It increases gap junction communications, anti-proliferation, pro-differentiation, and anti-lipid peroxidation activities.[4] Lycopene induces cytochrome P450 and hepatic quinine reductase which helps in the expulsion of carcinogens and foreign substances from the body. It inhibits phosphorylation of anti-oncogenes such as p53 and Rb.[4] It also inhibits G0/G1 and S-phase of the cell cycle.[56] Lycopene is observed to inhibit the activities of platelet-derived growth factor-BB, matrix metalloprotienases-2 (MMP-2), and MMP-9 resulting in decreased tumor growth, invasion, and metastasis.[5] It also regulates dysplastic changes and is of benefit in patients with oral premalignant lesions such as leukoplakia and initial stage of oral submucous fibrosis (OSMF).[237] In OSMF patients, lycopene increases mouth opening, decreases burning sensation of mouth, and inhibits abnormal fibroblasts and inflammation.[4] Lycopene is observed to inhibit fibrogenesis of hepatic tissues in LEC rats.[3] Lycopene is safe and has no adverse effects within a dietary dose of 3 g/kg/day.[8] Thus, lycopene with its anti-oxidant and multi-targeted anti-carcinogenic properties is of promising use in preventing and combating cancer.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  7 in total

1.  Efficacy of oral lycopene in the management of oral submucous fibrosis.

Authors:  A Ross Kerr
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2007-02

Review 2.  Multitargeted therapy of cancer by lycopene.

Authors:  Richard B van Breemen; Natasa Pajkovic
Journal:  Cancer Lett       Date:  2008-06-27       Impact factor: 8.679

Review 3.  Lycopene: features and potential significance in the oral cancer and precancerous lesions.

Authors:  Rui Lu; Hongxia Dan; Ruiqing Wu; Wenxia Meng; Na Liu; Xin Jin; Min Zhou; Xin Zeng; Gang Zhou; Qianming Chen
Journal:  J Oral Pathol Med       Date:  2010-12-30       Impact factor: 4.253

4.  Efficacy of lycopene in the management of oral submucous fibrosis.

Authors:  Abhinav Kumar; Anjana Bagewadi; Vaishali Keluskar; Mohitpal Singh
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2006-10-24

5.  Efficacy of oral lycopene in the treatment of oral leukoplakia.

Authors:  Mohitpal Singh; R Krishanappa; Anjana Bagewadi; Vaishali Keluskar
Journal:  Oral Oncol       Date:  2004-07       Impact factor: 5.337

Review 6.  Phytochemicals in cancer prevention and therapy: truth or dare?

Authors:  Maria Russo; Carmela Spagnuolo; Idolo Tedesco; Gian Luigi Russo
Journal:  Toxins (Basel)       Date:  2010-03-31       Impact factor: 4.546

Review 7.  Naturally occurring products in cancer therapy.

Authors:  E Rajesh; Leena S Sankari; L Malathi; Jayasri R Krupaa
Journal:  J Pharm Bioallied Sci       Date:  2015-04
  7 in total
  3 in total

1.  Effects of the Macular Carotenoid Lutein in Human Retinal Pigment Epithelial Cells.

Authors:  Xiaoming Gong; Christian S Draper; Geoffrey S Allison; Raju Marisiddaiah; Lewis P Rubin
Journal:  Antioxidants (Basel)       Date:  2017-12-04

Review 2.  Tomatoes: An Extensive Review of the Associated Health Impacts of Tomatoes and Factors That Can Affect Their Cultivation.

Authors:  Edward J Collins; Cressida Bowyer; Audrey Tsouza; Mridula Chopra
Journal:  Biology (Basel)       Date:  2022-02-04

Review 3.  Chemical diversity of dietary phytochemicals and their mode of chemoprevention.

Authors:  Srimanta Patra; Rabindra Nayak; Suryamani Patro; Biswajita Pradhan; Brundaban Sahu; Chhandashree Behera; Sujit Kumar Bhutia; Mrutyunjay Jena
Journal:  Biotechnol Rep (Amst)       Date:  2021-05-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.